These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 6882883)

  • 1. Steady-state distribution volume in physiologic multi-organ systems.
    Weiss M
    Biopharm Drug Dispos; 1983; 4(2):151-6. PubMed ID: 6882883
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetic concepts - drug binding, apparent volume of distribution and clearance.
    Gibaldi M; Koup JR
    Eur J Clin Pharmacol; 1981; 20(4):299-305. PubMed ID: 7308282
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Definition of pharmacokinetic parameters: influence of the sampling site.
    Weiss M
    J Pharmacokinet Biopharm; 1984 Apr; 12(2):167-75. PubMed ID: 6491899
    [TBL] [Abstract][Full Text] [Related]  

  • 4. On the accuracy of estimation of basic pharmacokinetic parameters by the traditional noncompartmental equations and the prediction of the steady-state volume of distribution in obese patients based upon data derived from normal subjects.
    Berezhkovskiy LM
    J Pharm Sci; 2011 Jun; 100(6):2482-97. PubMed ID: 21254063
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New physiologically based methods for calculating the apparent steady-state volume of distribution in pharmacokinetic studies.
    Chiou WL
    Int J Clin Pharmacol Ther Toxicol; 1982 Jun; 20(6):255-8. PubMed ID: 7107073
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Criticism of pharmacokinetic clearance concepts.
    Keller F; Schoole J
    Int J Clin Pharmacol Ther Toxicol; 1983 Nov; 21(11):563-8. PubMed ID: 6654532
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Advanced pharmacokinetic models based on organ clearance, circulatory, and fractal concepts.
    Pang KS; Weiss M; Macheras P
    AAPS J; 2007 Jun; 9(2):E268-83. PubMed ID: 17907768
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A physiologically based pharmacokinetic model to predict the pharmacokinetics of highly protein-bound drugs and the impact of errors in plasma protein binding.
    Ye M; Nagar S; Korzekwa K
    Biopharm Drug Dispos; 2016 Apr; 37(3):123-41. PubMed ID: 26531057
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Some considerations on the estimation of steady state apparent volume of distribution and the relationships between volume terms.
    Collier PS
    J Pharmacokinet Biopharm; 1983 Feb; 11(1):93-105. PubMed ID: 6875813
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetic parameters: which are necessary to define a drug substance?
    Benet LZ
    Eur J Respir Dis Suppl; 1984; 134():45-61. PubMed ID: 6586486
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Moments of physiological transit time distributions and the time course of drug disposition in the body.
    Weiss M
    J Math Biol; 1982; 15(3):305-18. PubMed ID: 7153675
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A valid equation for the well-stirred perfusion limited physiologically based pharmacokinetic model that consistently accounts for the blood-tissue drug distribution in the organ and the corresponding valid equation for the steady state volume of distribution.
    Berezhkovskiy LM
    J Pharm Sci; 2010 Jan; 99(1):475-85. PubMed ID: 19492340
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Theorems and implications of a model-independent elimination/distribution function decomposition of linear and some nonlinear drug dispositions. II. Clearance concepts applied to the evaluation of distribution kinetics.
    Gillespie WR; Veng-Pedersen P
    J Pharmacokinet Biopharm; 1985 Aug; 13(4):441-51. PubMed ID: 4087171
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distribution Clearance: Significance and Underlying Mechanisms.
    Weiss M
    Pharm Res; 2024 Jul; 41(7):1391-1400. PubMed ID: 38981900
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modelling of initial distribution of drugs following intravenous bolus injection.
    Weiss M
    Eur J Clin Pharmacol; 1983; 24(1):121-6. PubMed ID: 6832194
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A dispersion model of hepatic elimination: 2. Steady-state considerations--influence of hepatic blood flow, binding within blood, and hepatocellular enzyme activity.
    Roberts MS; Rowland M
    J Pharmacokinet Biopharm; 1986 Jun; 14(3):261-88. PubMed ID: 3783447
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationships between steady state blood concentrations and cardiac output during intravenous infusions.
    Upton RN
    Biopharm Drug Dispos; 2000 Mar; 21(2):69-76. PubMed ID: 11100908
    [TBL] [Abstract][Full Text] [Related]  

  • 18. On the accuracy of calculation of the mean residence time of drug in the body and its volumes of distribution based on the assumption of central elimination.
    Berezhkovskiy LM
    Xenobiotica; 2016; 46(6):477-82. PubMed ID: 26406808
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Some clarifications regarding moments of residence times with pharmacokinetic models.
    Beal SL
    J Pharmacokinet Biopharm; 1987 Feb; 15(1):75-92. PubMed ID: 3625481
    [TBL] [Abstract][Full Text] [Related]  

  • 20. On the determination of the time delay in reaching the steady state drug concentration in the organ compared to plasma.
    Berezhkovskiy LM
    J Pharm Sci; 2007 Dec; 96(12):3432-43. PubMed ID: 17628491
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.